AU2024275598A1 - Composition for preventing or treating cancer pain - Google Patents
Composition for preventing or treating cancer painInfo
- Publication number
- AU2024275598A1 AU2024275598A1 AU2024275598A AU2024275598A AU2024275598A1 AU 2024275598 A1 AU2024275598 A1 AU 2024275598A1 AU 2024275598 A AU2024275598 A AU 2024275598A AU 2024275598 A AU2024275598 A AU 2024275598A AU 2024275598 A1 AU2024275598 A1 AU 2024275598A1
- Authority
- AU
- Australia
- Prior art keywords
- optionally substituted
- halogen atoms
- group optionally
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023-086153 | 2023-05-25 | ||
| JP2023086153 | 2023-05-25 | ||
| PCT/JP2024/018940 WO2024242158A1 (ja) | 2023-05-25 | 2024-05-23 | がん性疼痛予防又は治療用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2024275598A1 true AU2024275598A1 (en) | 2026-01-15 |
Family
ID=93589461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2024275598A Pending AU2024275598A1 (en) | 2023-05-25 | 2024-05-23 | Composition for preventing or treating cancer pain |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4699608A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2024242158A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20260016503A (cg-RX-API-DMAC7.html) |
| CN (1) | CN121079089A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2024275598A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL324153A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025013810A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202508584A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024242158A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459240A1 (fr) | 1979-06-21 | 1981-01-09 | Cm Ind | Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent |
| DE69228017D1 (de) | 1991-03-27 | 1999-02-11 | Sanofi Sa | Verwendung von 4-Amino-1-(2-Pyridyl)Piperidinen als 5-HT3-Agonisten zur Behandlung und Verhütung von serotoninergen Dysfunktionen |
| ES2960385T3 (es) * | 2017-06-28 | 2024-03-04 | Univ Osaka | Tratamiento del dolor con agonista del receptor de serotonina-3 |
-
2024
- 2024-05-20 TW TW113118625A patent/TW202508584A/zh unknown
- 2024-05-23 WO PCT/JP2024/018940 patent/WO2024242158A1/ja not_active Ceased
- 2024-05-23 KR KR1020257041808A patent/KR20260016503A/ko active Pending
- 2024-05-23 AU AU2024275598A patent/AU2024275598A1/en active Pending
- 2024-05-23 CN CN202480031574.7A patent/CN121079089A/zh active Pending
- 2024-05-23 EP EP24811164.3A patent/EP4699608A1/en active Pending
- 2024-05-23 JP JP2025522445A patent/JPWO2024242158A1/ja active Pending
-
2025
- 2025-10-22 IL IL324153A patent/IL324153A/en unknown
- 2025-11-19 MX MX2025013810A patent/MX2025013810A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202508584A (zh) | 2025-03-01 |
| EP4699608A1 (en) | 2026-02-25 |
| CN121079089A (zh) | 2025-12-05 |
| WO2024242158A1 (ja) | 2024-11-28 |
| MX2025013810A (es) | 2025-12-01 |
| IL324153A (en) | 2025-12-01 |
| JPWO2024242158A1 (cg-RX-API-DMAC7.html) | 2024-11-28 |
| KR20260016503A (ko) | 2026-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11236058B2 (en) | Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia | |
| NO316309B1 (no) | Opiat-<kappa>-reseptoragonister, anti-kl degree emiddel, anvendelse og fremstilling derav | |
| EP3705474A1 (en) | Pharmaceutical composition for prevention or treatment of acute myeloid leukemia or metastatic breast cancer | |
| KR20130105613A (ko) | 오피오이드 유도성 통각과민에서의 시그마 리간드의 용도 | |
| KR20150065873A (ko) | 케타민 유도체 | |
| RU2554857C2 (ru) | Терапевтическое или профилактическое средство для заболеваний желчных путей | |
| KR20170131242A (ko) | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 | |
| TW201305148A (zh) | 5-甲基-1-(萘-2-基)-1h-吡唑衍生物類 | |
| KR101477043B1 (ko) | 디스키네시아의 치료 또는 예방제 | |
| JPS63162621A (ja) | 頻尿治療剤 | |
| EP4699608A1 (en) | Composition for preventing or treating cancer pain | |
| JP5100619B2 (ja) | ロキソプロフェン含有医薬製剤1 | |
| CA3289710A1 (en) | Composition for preventing or treating cancer pain | |
| KR102040639B1 (ko) | 히스타민-3 수용체 역효능제, 아세틸콜린에스테라제 저해제 및 nmda 수용체 길항제의 3중 조합물 | |
| US20250064761A1 (en) | Substituted benzamides and their use in therapy | |
| JP2023549394A (ja) | 注意欠陥/多動性障害の新規な治療 | |
| JP6734470B2 (ja) | ヒスタミン−3受容体インバースアゴニストとアセチルコリンエステラーゼ阻害剤との組合せ | |
| EP3646886A1 (en) | Treatment of pain with serotonin-3 receptor agonist | |
| CA2970256C (en) | Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists | |
| JP2772814B2 (ja) | 記憶障害改善剤 | |
| JP4357958B2 (ja) | オピオイド依存症の治療のためのピリジン−2−イル−メチルアミン誘導体 | |
| WO2016099394A1 (en) | Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression. | |
| JPWO2004063201A1 (ja) | 統合失調症治療剤 | |
| JPWO2001014382A1 (ja) | モルヒナン4級アンモニウム塩誘導体を有効成分とする鎮痛薬 | |
| HK1262796A1 (en) | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors |